title: Suvorexant-Induced Dream Enactment Behavior in Parkinson Disease: A Case Report.
abstract: Suvorexant is a new insomnia drug, and it is generally safe and well tolerated. Here, we report a rare but potentially important adverse effect of suvorexant in a patient with Parkinson disease.
authors.affiliation: Department of Neurology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
authors.forename: Hiromitsu
authors.initials: H
authors.lastname: Tabata
authors.affiliation: Department of General Medicine, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
authors.forename: Akira
authors.initials: A
authors.lastname: Kuriyama
authors.affiliation: Department of Neurology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
authors.forename: Fusae
authors.initials: F
authors.lastname: Yamao
authors.affiliation: Department of Neurology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kitaguchi
authors.affiliation: Department of Neurology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
authors.forename: Katsuro
authors.initials: K
authors.lastname: Shindo
mesh_terms: D000368:Aged; D001381:Azepines / Q000009:adverse effects* / Q000627:therapeutic use; D004325:Dreams / Q000187:drug effects; D006801:Humans; D008297:Male; D020447:Parasomnias / Q000139:chemically induced* / Q000150:complications; D010300:Parkinson Disease / Q000150:complications*; D000068776:Sleep Aids, Pharmaceutical / Q000009:adverse effects* / Q000627:therapeutic use; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D001381:Azepines; D000068776:Sleep Aids, Pharmaceutical; D014230:Triazoles; C551624:suvorexant
keywords: Parkinson disease; REM sleep behavioral disorder; nightmare; polysomnography; suvorexant